Brown Advisory Securities, LLC Exelixis, Inc. Transaction History

Brown Advisory Securities, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$16.3 - $21.14 $326,000 - $422,800	-20,000 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$18.93 - $24.75 $18,664 - $24,403	-986 Reduced 4.7%	20,000 $427,000
Q1 2019 May 14, 2019	BUY	$19.6 - $24.76 $19,325 - $24,413	986 Added 4.93%	20,986 $500,000
Q2 2017 Aug 14, 2017	BUY	N/A	20,000	20,000 $493,000

462

246M

1.7M

1.02M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $7.1B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Brown Advisory Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Securities, LLC with notifications on news.